gene synthesis

In a proof-of-concept study published in Nature Biotechnology this week, the team demonstrated that it could enzymatically synthesize 10-mer oligonucleotides.

GenScript believes that CustomArray's oligonucleotide synthesis and microarray manufacturing technology will enable it to better serve its customers.

Genome Compiler will integrate DNA2.0's gene synthesis services into its computer-aided synthetic biology design platform.

NEW YORK (GenomeWeb News) – Genewiz and KeyTest Diagnostics today announced a collaboration aimed at developing molecular diagnostic tests for the Chinese market.

NEW YORK (GenomeWeb News) – Eurofins MWG Operon today announced it has acquired gene synthesis firm Entelechon for an undisclosed amount.

NEW YORK (GenomeWeb News) – The US Department of Energy's Joint Genome Institute has funded six new initiatives to develop technologies that will help JGI and its users conduct their research efforts into microbiology, metagenomics, and plant genomics.

Synthetic Genomics said this week that it has purchased from Febit Holding GmbH the worldwide rights to three families of patents and patent applications related to gene synthesis.

NEW YORK (GenomeWeb News) – An interdisciplinary team of Virginia Tech scientists have won a $1 million award from the National Science Foundation that they will use to optimize the processes and tools used for building custom DNA molecules and to train young researchers and students in DNA synth

The researchers believe their gene synthesis platform will prove "faster and cheaper" than alternative array-based approaches, as well as traditional methods of gene assembly.

The team is currently seeking investors and partners in order to spin out a new company and set up a facility for the gene synthesis service, which it believes it could begin offering within the next one to two years at a price of 6 to 9 cents per base pair.

Pages

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

NPR reports that government and private insurers are being slow to cover recently approved CAR-T cell therapies.